LobbyingPam Health Fka Post Acute Medical lobbying by quarter
Pam Health Fka Post Acute Medical's latest lobbying report covers Q2 2026, at $24.4K. The four quarters Q4 2025–Q3 2026 total $63K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Pam Health Fka Post Acute Medical
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $63K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20.1K | 1 |
| Q1 2023 | $13.4K | 1 |
| Q2 2023 | $26.8K | 1 |
| Q3 2023 | $20.1K | 1 |
| Q4 2023 | $20.1K | 1 |
| Q1 2024 | $13.4K | 1 |
| Q2 2024 | $28.8K | 1 |
| Q3 2024 | $21.6K | 1 |
| Q4 2024 | $21.6K | 1 |
| Q1 2025 | $14.4K | 1 |
| Q2 2025 | $30.9K | 1 |
| Q3 2025 | $23.2K | 1 |
| Q4 2025 | $23.2K | 1 |
| Q1 2026 | $15.5K | 1 |
| Q2 2026 | $24.4K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$44.3K · 4 reports
- Medicare and Medicaid$44.3K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Debrunner & Associates | $317.4K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ELLEN J KUGLER | Federal Legislative Consultant | Q3 2024 |
| KATE FINKELSTEIN | Federal Legislative Consultant | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Debrunner & Associates | $24.4K |
| 07/20for Q2 | Debrunner & Associates | $24.4K |
| 04/20for Q1 | Debrunner & Associates | $15.5K |
| 01/18for Q4 2025 | Debrunner & Associates | $23.2K |
| 25/10/17for Q3 2025 | Debrunner & Associates | $23.2K |
| 25/07/14for Q2 2025 | Debrunner & Associates | $30.9K |
| 25/04/21for Q1 2025 | Debrunner & Associates | $14.4K |
| 25/01/21for Q4 2024 | Debrunner & Associates | $21.6K |
| 24/10/10for Q3 2024 | Debrunner & Associates | $21.6K |
| 24/07/17for Q2 2024 | Debrunner & Associates | $28.8K |
| 24/04/18for Q1 2024 | Debrunner & Associates | $13.4K |
| 24/01/12for Q4 2023 | Debrunner & Associates | $20.1K |
| 23/10/20for Q3 2023 | Debrunner & Associates | $20.1K |
| 23/07/20for Q2 2023 | Debrunner & Associates | $26.8K |
| 23/04/18for Q1 2023 | Debrunner & Associates | $13.4K |
| 23/01/19for Q4 2022 | Debrunner & Associates | $20.1K |